Stock FOLD AMICUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Amicus Therapeutics, Inc.

Equities

FOLD

US03152W1099

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
10.4 USD -0.29% Intraday chart for Amicus Therapeutics, Inc. +1.17% -26.71%
03-18 JPMorgan Adjusts Price Target on Amicus Therapeutics to $19 From $21, Maintains Overweight Rating MT
03-05 Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
AQ
Amicus Therapeutics : ESG Report
PU
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
AQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
AQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
AQ
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
AQ
Amicus Therapeutics : Fourth Quarter and Full Year 2023 Results Conference Call and Webcast
PU
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
AQ
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti + Opfolda at the 20th Annual WORLDSymposium
AQ
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
AQ
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
AQ
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
AQ
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AQ
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
AQ
Amicus Therapeutics: Q3 Earnings Snapshot
AQ
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
AQ
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
AQ
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
AQ
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
AQ
Amicus Therapeutics : Termination of Material Agreement - Form 8-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FOLD Stock
  4. News Amicus Therapeutics, Inc.
  5. Press Releases